Insights

Personalized Therapy Kiyatec offers patient-specific ex vivo 3D tumor models to predict treatment response, creating a strong sales angle for pharma and hospitals seeking precision oncology solutions to reduce ineffective therapies and improve outcomes.

Clinical Validation Established connections with leading cancer hospitals, top pharmaceutical companies, and the NCI provide a credible pathway for partnerships, co development, and adoption of their predictive platform in clinical workflows.

Strategic Leadership Recent leadership changes and high profile advisors including former Myriad Genetics CEO and experienced executives signal a growth trajectory and openness to strategic collaborations, which can be leveraged for enterprise deals and joint ventures.

Funding Momentum Recent $18M Series C and continued investor engagement indicate financial stability and potential for scale up partnerships, particularly with biotech, CROs, and biopharma looking to augment drug development with predictive assays.

Targeted Expansion Bruker’s investment and the company’s CLIA-certified labs position Kiyatec for partnerships with diagnostic and instrumentation vendors, contract research organizations, and hospital systems seeking integrated solutions for therapy selection and clinical trials.

Similar companies to Kiyatec Inc.

Kiyatec Inc. Tech Stack

Kiyatec Inc. uses 8 technology products and services including Linkedin Insight Tag, iCIMS, WordPress, and more. Explore Kiyatec Inc.'s tech stack below.

Media & News

Kiyatec Inc.'s Email Address Formats

Kiyatec Inc. uses at least 2 email formats:
Kiyatec Inc. Email FormatsExamplePercentage
First.Last@kiyatec.comJohn.Doe@kiyatec.com
97%
First@kiyatec.comJohn@kiyatec.com
3%

Frequently Asked Questions

What is Kiyatec Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Kiyatec Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Kiyatec Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Kiyatec Inc.'s official website is kiyatec.com and has social profiles on LinkedIn.

How much revenue does Kiyatec Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Kiyatec Inc.'s annual revenue is estimated to be $10M - $25M.

What is Kiyatec Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Kiyatec Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Kiyatec Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Kiyatec Inc. has approximately 14 employees across 3 continents, including North America, Asia and Africa. Key team members include Chief Medical Officer: H. E., Strategic Account Specialist: M. R. L. and Cofounder: M. G. Explore Kiyatec Inc.'s employee directory with LeadIQ.

What industry does Kiyatec Inc. belong to?

Minus sign iconPlus sign icon
Kiyatec Inc. operates in the Biotechnology Research industry.

What technology does Kiyatec Inc. use?

Minus sign iconPlus sign icon
Kiyatec Inc.'s tech stack includes Linkedin Insight Tag, iCIMS, WordPress, StackAdapt, Shopify, Google Workspace, Microsoft 365 and WP Engine.

What is Kiyatec Inc.'s email format?

Minus sign iconPlus sign icon
Kiyatec Inc.'s email format typically follows the pattern of First.Last@kiyatec.com. Find more Kiyatec Inc. email formats with LeadIQ.

When was Kiyatec Inc. founded?

Minus sign iconPlus sign icon
Kiyatec Inc. was founded in 2010.
Kiyatec Inc. logo

Kiyatec Inc.

Biotechnology ResearchSouth Carolina, United States11-50 Employees

Kiyatec Inc. is a biotechnology research company based in Greenville, South Carolina, focusing on predicting patient-specific responses to cancer therapies before treatment begins. The firm uses a patient’s living tumor cells to create functional 3D models in its CLIA-certified laboratories, testing multiple therapies to identify which treatments are likely to be effective for an individual. This approach aims to help physicians quickly narrow to the most suitable options, advancing personalized medicine in oncology. The company engages with major cancer centers and pharmaceutical organizations to validate its methodology and is conducting clinical trials to demonstrate its potential across a broad portfolio of predictive products. Recent leadership and strategic appointments reflect ongoing efforts to strengthen its scientific and strategic direction.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    Kiyatec Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.